Pure Global

Axonics Neurostimulator - Stimulator, electrical, neuromuscular, incontinence, implantable

Access comprehensive regulatory information for Axonics Neurostimulator - Stimulator, electrical, neuromuscular, incontinence, implantable in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class III is sponsored by Axonics Modulation Technologies Australia Pty Ltd, manufactured by Axonics Inc in United States of America. The device registration started on June 15, 2022.

This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.

Free Database
Powered by Pure Global AI
TGA ARTG Official Data
Class III
Class III
Axonics Neurostimulator - Stimulator, electrical, neuromuscular, incontinence, implantable
Australia TGA ARTG Registered Device
Good Name: Axonics Modulation Technologies Australia Pty Ltd - Axonics Neurostimulator - Stimulator, electrical, neuromuscular, incontinence, implantable
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Intended Purpose

The neurostimulator is an implantable device intended to treat urinary and/or faecal incontinence.

Device Classification
Risk Class
Class III
Product Type
Single Device Product
ARTG Category
General
Registration Information
Start Date
June 15, 2022
Effective Date
June 15, 2022
Manufacturer
Country
United States of America
Address
26 Technology Drive, Irvine, California, 92618